Skip to content
10-K

Annual Report

Tobira Therapeutics, Inc.

0001564590-16-013992

← back to feed
Filed
Mar 3, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Feb 26, 2016 18.82M sh
Capex FY 2015 · Dec 31, 2015 $39K
Capex restated FY 2015 · Dec 31, 2014 $180K
Capex restated FY 2015 · Dec 31, 2013 $1K
Long Term Debt FY 2015 · Dec 31, 2015 $15.07M
Long Term Debt FY 2015 · Dec 31, 2014 $14.79M
Cash And Equivalents FY 2015 · Dec 31, 2015 $62.43M
Cash And Equivalents restated FY 2015 · Dec 31, 2014 $6.18M
Cash And Equivalents restated FY 2015 · Dec 31, 2013 $4.09M
Cash And Equivalents restated FY 2015 · Dec 31, 2012 $10.94M
Stockholders Equity FY 2015 · Dec 31, 2015 $42.77M
Stockholders Equity restated FY 2015 · Dec 31, 2014 −$109.38M
Stockholders Equity restated FY 2015 · Dec 31, 2013 −$86M
Stockholders Equity restated FY 2015 · Dec 31, 2012 −$69.02M
Current Liabilities FY 2015 · Dec 31, 2015 $7.42M
Current Liabilities restated FY 2015 · Dec 31, 2014 $38.24M
Total Liabilities FY 2015 · Dec 31, 2015 $22.7M
Total Liabilities restated FY 2015 · Dec 31, 2014 $55.75M
Current Assets FY 2015 · Dec 31, 2015 $63.25M
Current Assets restated FY 2015 · Dec 31, 2014 $7.19M
Total Assets FY 2015 · Dec 31, 2015 $65.47M
Total Assets restated FY 2015 · Dec 31, 2014 $8.35M
Sga Expense FY 2015 · Dec 31, 2015 $2.77M
Sga Expense FY 2015 · Dec 31, 2015 $10.87M
Sga Expense FY 2015 · Sep 30, 2015 $2.83M
Sga Expense FY 2015 · Jun 30, 2015 $3.12M
Sga Expense FY 2015 · Mar 31, 2015 $2.15M
Sga Expense FY 2015 · Dec 31, 2014 $5.09M
Sga Expense restated FY 2015 · Dec 31, 2014 $7.84M
Sga Expense FY 2015 · Sep 30, 2014 $12K
Sga Expense FY 2015 · Jun 30, 2014 $1.87M
Sga Expense FY 2015 · Mar 31, 2014 $869K
Sga Expense restated FY 2015 · Dec 31, 2013 $2.76M
Rd Expense FY 2015 · Dec 31, 2015 $6.29M
Rd Expense FY 2015 · Dec 31, 2015 $24.67M
Rd Expense FY 2015 · Sep 30, 2015 $6.09M
Rd Expense FY 2015 · Jun 30, 2015 $6.62M
Rd Expense FY 2015 · Mar 31, 2015 $5.67M
Rd Expense FY 2015 · Dec 31, 2014 $3.91M
Rd Expense restated FY 2015 · Dec 31, 2014 $12.18M
Rd Expense FY 2015 · Sep 30, 2014 $3.51M
Rd Expense FY 2015 · Jun 30, 2014 $3.09M
Rd Expense FY 2015 · Mar 31, 2014 $1.67M
Rd Expense restated FY 2015 · Dec 31, 2013 $12.41M
Net Income FY 2015 · Dec 31, 2015 −$9.39M
Net Income FY 2015 · Dec 31, 2015 −$49.62M
Net Income FY 2015 · Sep 30, 2015 −$22.21M
Net Income FY 2015 · Jun 30, 2015 −$10.99M
Net Income FY 2015 · Mar 31, 2015 −$7.03M
Net Income FY 2015 · Dec 31, 2014 −$10.41M
Net Income restated FY 2015 · Dec 31, 2014 −$24.1M
Net Income FY 2015 · Sep 30, 2014 −$2.94M
Net Income FY 2015 · Jun 30, 2014 −$7.92M
Net Income FY 2015 · Mar 31, 2014 −$2.83M
Net Income restated FY 2015 · Dec 31, 2013 −$18.59M
Operating Income FY 2015 · Dec 31, 2015 −$52.86M
Operating Income restated FY 2015 · Dec 31, 2014 −$20.02M
Operating Income restated FY 2015 · Dec 31, 2013 −$15.18M